CLOs on the Move

Stryker

www.stryker.com

 
Stryker is one of the world`s leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.stryker.com
  • 2825 Airview Boulevard
    Kalamazoo, MI USA 49002
  • Phone: 269.385.2600

Executives

Name Title Contact Details
Josh Sabloff
Deputy General Counsel, Commerical Profile
Hardin Kimmel
Senior Compliance Officer Profile
Sean Etheridge
Vice President, Senior Counsel and Corporate Secretary Profile
Matt Harrow
Director Of Intellectual Property Profile
Melissa Reynolds
Senior Director, Legal Counsel, Global Quality and Operations Profile

Similar Companies

Mitchell Planning

Mitchell Planning is a Northbrook, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Specialty Medical Supply

Specialty Medical Supply is a Batavia, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Distribution Solutions

Medical Distribution Solutions is a Lawrenceville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Southeast Michigan Surgical Hospital

Southeast Michigan Surgical Hospital is a Warren, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

JenaValve

JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.